Cite
HARVARD Citation
Niesor, E. et al. (2014). Treatment of Low HDL‐C Subjects with the CETP Modulator Dalcetrapib Increases Plasma Campesterol Only in Those Without ABCA1 and/or ApoA1 Mutations. Lipids. 49 (12), pp. 1245-1249. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Niesor, E. et al. (2014). Treatment of Low HDL‐C Subjects with the CETP Modulator Dalcetrapib Increases Plasma Campesterol Only in Those Without ABCA1 and/or ApoA1 Mutations. Lipids. 49 (12), pp. 1245-1249. [Online].